Only got +5.5% in the US overnight because a) the news was expected given their communications to date and b) the underlying issue with the company remains the same - growth has fallen away and they've taken on a US$90M debt facility - of which US$40M has already been drawn down (the full amount available to them). Obviously any FDA approval is a positive step, but the debt profile now completely changes the risk/reward situation.
Only got +5.5% in the US overnight because a) the news was...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.99 |
Change
-0.070(2.29%) |
Mkt cap ! $210.5M | |||
| Open | High | Low | Value | Volume |
| $3.00 | $3.05 | $2.98 | $259.6K | 86.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4898 | $2.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.02 | 3305 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |